TJ Bilodeau Joins Medicines for Humanity Board of Directors
Following in his father’s footsteps and continuing the family legacy of helping to save the lives of innocent children around the world, TJ Bilodeau, son of Medicines for Humanity (MFH) Founder Tim Bilodeau, has joined the MFH Board of Directors.
TJ is a Principal at L.E.K. Consulting, a global strategy consulting firm, and is a senior member of the firm’s Healthcare practice. He supports clients across the healthcare industry with a focus on growth strategy for emerging and mid-size biopharma. During his career, TJ has worked across several therapeutic areas and has extensive experience in commercialization strategy, portfolio optimization, transaction support, and broader strategic planning. He recently led and remains on the Steering Committee of L.E.K.’s Global Healthcare Insights Center.
TJ is a graduate of Harvard College where he earned a Bachelor of Science degree in Government. “We are so thrilled to have TJ on our Board,” stated Kirk Ryan, MFH Board Chair. “He and his wife Julie have supported our mission and our work for a long time and we are delighted to have him with us in this ‘official’ role now.”